Tandem Diabetes Care, Inc.TNDMNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +95.71% | +43.62% | +22.30% | +8.46% | -31.39% |
| Gross Profit Growth | +38.88% | +68.77% | +25.07% | +11.58% | +7.73% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.65% | +0.87% | +1.65% | +3.16% | +3.23% |
| Weighted Average Shares Diluted Growth | +0.65% | +1.21% | +1.65% | +3.16% | +3.23% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +48589.09% | +0.00% | +0.00% | +0.00% | -69.14% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | -80.63% |
| Receivables Growth | +6.85% | +8.55% | +36.14% | +30.91% | +17.49% |
| Inventory Growth | +6.24% | -5.27% | -8.27% | -11.81% | -9.94% |
| Asset Growth | +1.90% | +1.57% | -2.01% | -6.59% | -8.67% |
| Book Value per Share Growth | -24.78% | -16.84% | -37.15% | -44.76% | -45.81% |
| Debt Growth | +13.81% | +13.93% | +3.28% | -5.89% | -5.60% |
| R&D Expense Growth | +21.77% | +22.52% | +171.24% | -2.45% | -6.31% |
| SG&A Expenses Growth | +25.60% | +23.42% | +26.35% | +16.29% | +6.86% |